Pravigard PAC, the first statin and aspirin combo

August 2003

Bristol-Myers Squibb is now marketing Pravigard PAC, the first statin and aspirin combo.

It's approved to prevent MIs, strokes, and death in patients who already have cardiovascular disease.

But it can also be used in other patients who are candidates for both pravastatin and aspirin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote